Lilly Wong
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Immunology top 10%
- Immune Cell Function and Interaction
Papers in
-
- Protein Degradation and Inhibitors 6
- Protein Kinase Regulation and GTPase Signaling 6
- PI3K/AKT/mTOR signaling in cancer 6
- Oncology 19
- CAR-T cell therapy research 12
- Co-authors
- Patricia A. Jennings (7 shared papers)Joseph A. Adams (6 shared papers)Palmer Taylor (4 shared papers)Zoran Radić (3 shared papers)Guochun Jiang (7 shared papers)Harvey Alan Berman (2 shared papers)Natilie Hosea (2 shared papers)Roger J. M. Brüggemann (2 shared papers)
- Journals
- Blood (12 papers)Journal of Clinical Oncology (6 papers)Journal of Molecular Biology (3 papers)Journal of Biological Chemistry (3 papers)iScience (2 papers)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Lilly Wong
47 papers receiving 1.1k citations
Lilly Wong's Hit Papers
Peers
Comparison fields: 5 of 93
- Oncology 324
- Immunology 215
- Hematology 104
- Virology 42
- Pharmacology 135
Countries citing papers authored by Lilly Wong
This map shows the geographic impact of Lilly Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lilly Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lilly Wong more than expected).
Fields of papers citing papers by Lilly Wong
This network shows the impact of papers produced by Lilly Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lilly Wong. The network helps show where Lilly Wong may publish in the future.
Co-authors
The 25 scholars most cited alongside Lilly Wong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 109 | |
| 2 | 2002 | 69 | |
| 3 | 2021 | 68 | |
| 4 | Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial Hit paper breakdown → | 2025 | 66 |
| 5 | 2015 | 62 | |
| 6 | 2005 | 51 | |
| 7 | 2017 | 51 | |
| 8 | 2022 | 44 | |
| 9 | 2004 | 39 | |
| 10 | 2020 | 38 | |
| 11 | 2022 | 38 | |
| 12 | 2005 | 36 | |
| 13 | 2020 | 36 | |
| 14 | 2008 | 31 | |
| 15 | 2021 | 30 | |
| 16 | 2004 | 24 | |
| 17 | 2000 | 23 | |
| 18 | 1999 | 20 | |
| 19 | 2019 | 19 | |
| 20 | 2004 | 18 |
About Lilly Wong
Lilly Wong is a scholar working on Molecular Biology, Oncology, Hematology, Immunology and Epidemiology, having authored 47 papers that have together received 1.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (12 papers), Multiple Myeloma Research and Treatments (8 papers), Protein Degradation and Inhibitors (6 papers), Protein Kinase Regulation and GTPase Signaling (6 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Immune Cell Function and Interaction (5 papers), Cytomegalovirus and herpesvirus research (5 papers) and HIV Research and Treatment (5 papers). The work is most often cited by research in Oncology (324 citations), Immunology (215 citations), Hematology (104 citations), Virology (42 citations) and Pharmacology (135 citations). Lilly Wong has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Patricia A. Jennings, Joseph A. Adams, Palmer Taylor, Zoran Radić, Guochun Jiang, Harvey Alan Berman, Natilie Hosea, Roger J. M. Brüggemann, Virgil L. Woods and Bahram Valamehr. Their work appears in journals such as Blood, Journal of Clinical Oncology, Journal of Molecular Biology, Journal of Biological Chemistry and iScience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.